Abstract Context The European Association of Urology (EAU) guidelines panel on upper
urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in …

Simple Summary The clinical management of bladder cancer has been developing in the
past decade, including diagnostic tools and treatment options. Both monotherapy and …

We systematically reviewed the literature and summarized oncologic and safety outcomes
for endoscopic management (EM) compared to radical nephroureterectomy (RNU) for …

Cancer immunotherapies have revolutionized the treatment of numerous cancers, with
exciting results often superior to conventional treatments, such as surgery and …

Simple Summary Upper tract urothelial carcinoma (UTUC) is a lethal cancer of the urinary
tract. Radical nephroureterectomy with bladder cuff excision is the gold standard for the …

Upper tract urothelial carcinoma (UTUC) is a rare malignancy, occurring in 5–10% of
patients diagnosed with UC, and involves the renal pelvis, calyces, or ureters. UTUC can be …

Purpose: We describe a novel application of the reverse thermal polymer gel of mitomycin C
(UGN-101) as adjuvant therapy after complete endoscopic ablation of upper tract urothelial …

A major limitation of the treatment of low-grade upper tract urothelial carcinoma is the
difficulty of intracavitary instillation of adjuvant therapy. Therefore, the aim of this in vitro …

Current guidelines recommend endoscopic management (EM) for patients with low‐risk
upper urinary tract urothelial carcinoma, as well as those with an imperative indication …

Simple Summary This comprehensive review discusses the current status and future
prospects of intravesical therapy for upper urinary tract urothelial carcinoma (UTUC). It …